Status:
COMPLETED
Anti-inflammatory and Antioxidant Effects of Resveratrol on Healthy Adults.
Lead Sponsor:
University of Turin, Italy
Conditions:
Chronic Subclinic Inflammation
Redox Status
Eligibility:
All Genders
20-50 years
Phase:
PHASE3
Brief Summary
This research will investigate the hypothesis that resveratrol when given orally to healthy adult smokers induces a decrease in the inflammatory and oxidative mediators which characterize the low-grad...
Detailed Description
The effect of resveratrol in humans is still not well defined. The number of studies on resveratrol has increased extraordinarily since 1997, when its anticancer effect has been reported. However, mos...
Eligibility Criteria
Inclusion
- age 20-50 years
- actual smoking (≥5 cigarettes/die)
- mean alcohol consumption \<30g/day
- absence of known hyperglycaemia, hypertension, cardiovascular disease, impaired renal function, liver disease, or any other systemic conditions -no use of any drug -oestrogen excluded-
- not being on a particular diet and/or vitamin or other nutrient or integrator supplementation during the least 6-months
Exclusion
- actual pregnancy -known hyperglycaemia, hypertension, cardiovascular disease, impaired renal function, liver disease, or any other systemic chronic or acute conditions, use of any drug -oestrogen excluded-
- being on a particular diet and/or vitamin or other nutrient or integrator supplementation during the last six months
- mean alcohol consumption ≥30g/day
- body mass index (BMI)\>30 kg/m2
- subject unable to give his/her informed consent.
Key Trial Info
Start Date :
July 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01492114
Start Date
July 1 2011
End Date
March 1 2012
Last Update
July 10 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Simona Bo
Turin, Turin, Italy, 10126